Skip to main content

Table 2 Cointerventions received according to corticosteroid treatment status among critically ill patients with H1N1pdm09

From: The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness

Cointervention

All patientsa (n = 607)

Not treated with corticosteroids (n = 327)

Treated with corticosteroids (n = 280)

p Value

Mechanical ventilation, day 1

392 (66.2)

212 (67.5)

180 (64.8)

0.48

Mechanical ventilation, any

535 (89.2)

275 (85.4)

260 (93.5)

0.001

Rescue oxygenation strategy, any

98 (16.1)

39 (11.9)

59 (21.1)

0.002

 ECMO

18 (3.0)

10 (3.1)

8 (2.9)

0.88

 HFOV

61 (10.1)

27 (8.3)

34 (12.1)

0.11

Nitric oxide

52 (8.6)

21 (6.4)

31 (11.1)

0.04

Prone ventilation

11 (1.8)

3 (0.9)

8 (2.9)

0.07

Antibiotic treatment, day 1

382 (63.9)

199 (60.9)

183 (65.4)

0.25

Antibiotic treatment, any

588 (96.9)

317 (96.9)

271 (96.8)

0.91

Neuraminidase inhibitor treatment, day 1

316 (52.1)

166 (50.8)

150 (53.6)

0.49

Neuraminidase inhibitor treatment, any

564 (92.9)

294 (89.9)

270 (96.4)

0.002

Vasopressor treatment, day 1

251 (41.4)

131 (40.1)

120 (42.9)

0.49

Vasopressor treatment, any

334 (55.0)

171 (52.3)

163 (58.2)

0.14

  1. ECMO extracorporeal membrane oxygenation; HFOV high-frequency oscillation ventilation; Day 1 first day in intensive care unit
  2. Data are presented as number (%). Some patients received more than 1 rescue strategy.
  3. aDenominators may vary for each category